author-photo

Kazumasa Miyawaki

Takeda Pharmaceutical Company

3

Papers

80

Citations

Citation Trend

Filter By

Papers (1) Sort By

Journal Conference Others

Fasiglifam/TAK-875, a Selective GPR40 Agonist, Improves Hyperglycemia in Rats Unresponsive to Sulfonylureas and Acts Additively with Sulfonylureas.

2016 Journal of Pharmacology and Experimental Therapeutics
Show All
- Source
- Cite
- Save
Citations (10)